Lite Strategy (LITS) Other Non-Current Assets (2024 - 2026)
Lite Strategy (LITS) posted Other Non-Current Assets of $678000.0 for Q1 2026, down 3.83% on a QoQ basis from $705000.0 in Q4 2025.
Analysis
Lite Strategy (LITS) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Lite Strategy has reported Other Non-Current Assets for 3 years, with the latest figure at $678000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $678000.0 in Q1 2026; TTM through Mar 2026 was $678000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $263000.0, changed N/A from the prior year.
- Other Non-Current Assets was $678000.0 for Q1 2026 at Lite Strategy, down from $705000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $732000.0 in Q3 2025, with the low at $263000.0 in Q2 2024.
- Average Other Non-Current Assets over 3 years is $528200.0, with a median of $678000.0 recorded in 2026.
- The largest YoY upside for Other Non-Current Assets was 178.33% in 2025 against a maximum downside of 178.33% in 2025.
- Over 3 years, Other Non-Current Assets stood at $263000.0 in 2024, then surged by 168.06% to $705000.0 in 2025, then declined by 3.83% to $678000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $678000.0 (Q1 2026), $705000.0 (Q4 2025), and $732000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 29.59 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | 678,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 678,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Sep 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 263,000.00 |